These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942 [TBL] [Abstract][Full Text] [Related]
3. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Fluechter S; Kuschyk J; Wolpert C; Doesch C; Veltmann C; Haghi D; Schoenberg SO; Sueselbeck T; Germans T; Streitner F; Borggrefe M; Papavassiliu T J Cardiovasc Magn Reson; 2010 May; 12(1):30. PubMed ID: 20492668 [TBL] [Abstract][Full Text] [Related]
4. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia. Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900 [TBL] [Abstract][Full Text] [Related]
5. Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy. Ye Y; Ji Z; Zhou W; Pu C; Li Y; Zhou C; Hu X; Chen C; Sun Y; Huang Q; Zhang W; Qian Y; Ren H; Yu F; Jiang C; Mao Y; Wang B; Augusto JB; Lai D; Hu H; Fu GS Front Cardiovasc Med; 2021; 8():758635. PubMed ID: 34869672 [No Abstract] [Full Text] [Related]
6. Late gadolinium enhancement on cardiac magnetic resonance represents the depolarizing and repolarizing electrically damaged foci causing malignant ventricular arrhythmia in hypertrophic cardiomyopathy. Sakamoto N; Kawamura Y; Sato N; Nimura A; Matsuki M; Yamauchi A; Kanno T; Tanabe Y; Takeuchi T; Natori S; Saijo Y; Aburano T; Hasebe N Heart Rhythm; 2015 Jun; 12(6):1276-84. PubMed ID: 25684235 [TBL] [Abstract][Full Text] [Related]
7. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595 [TBL] [Abstract][Full Text] [Related]
8. High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia. Hennig A; Salel M; Sacher F; Camaioni C; Sridi S; Denis A; Montaudon M; Laurent F; Jais P; Cochet H Europace; 2018 Sep; 20(FI2):f179-f191. PubMed ID: 29069369 [TBL] [Abstract][Full Text] [Related]
9. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study. Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853 [TBL] [Abstract][Full Text] [Related]
10. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia. Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568 [TBL] [Abstract][Full Text] [Related]
12. Scar border zone mass and presence of border zone channels assessed with cardiac magnetic resonance imaging are associated with ventricular arrhythmia in patients with ST-segment elevation myocardial infarction. Thomsen AF; Bertelsen L; Jøns C; Jabbari R; Lønborg J; Kyhl K; Göransson C; Nepper-Christensen L; Atharovski K; Ekström K; Tilsted HH; Pedersen F; Køber L; Engstrøm T; Vejlstrup N; Jacobsen PK Europace; 2023 Mar; 25(3):978-988. PubMed ID: 36576342 [TBL] [Abstract][Full Text] [Related]
13. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure. Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767 [TBL] [Abstract][Full Text] [Related]
14. Increased extent of myocardial fibrosis in genotyped hypertrophic cardiomyopathy with ventricular tachyarrhythmias. Fujita T; Konno T; Yokawa J; Masuta E; Nagata Y; Fujino N; Funada A; Hodatsu A; Kawashiri MA; Yamagishi M; Hayashi K J Cardiol; 2015 Jul; 66(1):63-8. PubMed ID: 25458192 [TBL] [Abstract][Full Text] [Related]
15. Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy. Piers SR; Androulakis AF; Yim KS; van Rein N; Venlet J; Kapel GF; Siebelink HM; Lamb HJ; Cannegieter SC; Man SC; Zeppenfeld K Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e009979. PubMed ID: 35089806 [TBL] [Abstract][Full Text] [Related]
16. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance. Mavrogeni S; Petrou E; Kolovou G; Theodorakis G; Iliodromitis E Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):518-25. PubMed ID: 23324829 [TBL] [Abstract][Full Text] [Related]
17. Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR. Avanesov M; Münch J; Weinrich J; Well L; Säring D; Stehning C; Tahir E; Bohnen S; Radunski UK; Muellerleile K; Adam G; Patten M; Lund G Eur Radiol; 2017 Dec; 27(12):5136-5145. PubMed ID: 28616729 [TBL] [Abstract][Full Text] [Related]
18. Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy. Barbosa AR; Almeida J; Guerreiro C; Teixeira P; Ladeiras Lopes R; Dias Ferreira N; Sousa O; Braga P Rev Port Cardiol (Engl Ed); 2020 Nov; 39(11):615-621. PubMed ID: 33168362 [TBL] [Abstract][Full Text] [Related]
19. Quality assessment of cardiac magnetic resonance myocardial scar imaging prior to ventricular arrhythmia ablation. Shah R; Sharma A; Assis F; De Vasconcellos HD; Alugubelli N; Pandey P; Akhtar T; Gasperetti A; Zhou S; Halperin H; Zimmerman SL; Tandri H; Kolandaivelu A Int J Cardiovasc Imaging; 2023 Feb; 39(2):411-421. PubMed ID: 36331683 [TBL] [Abstract][Full Text] [Related]
20. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis. Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]